Householder Group Estate & Retirement Specialist’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$287K Sell
3,341
-623
-16% -$67.4K 0.21% 79
2024
Q3
$471K Sell
3,964
-13
-0.3% -$1.73K 0.14% 142
2024
Q2
$567K Buy
3,977
+141
+4% +$18.7K 0.16% 122
2024
Q1
$493K Buy
3,836
+18
+0.5% +$2.14K 0.15% 137
2023
Q4
$395K Buy
3,818
+2,290
+150% +$226K 0.13% 148
2023
Q3
$139K Buy
+1,528
New +$135K 0.05% 263
2023
Q1
$121K Buy
+1,520
New +$108K 0.05% 264
2022
Q4
Sell
-1,518
Closed -$75K 840
2022
Q3
$75K Buy
+1,518
New +$81.3K 0.03% 318

Other funds holding NVO

Householder Group Estate & Retirement Specialist's NVO Position: Q4 2024 in Review

Householder Group Estate & Retirement Specialist reduced its Novo Nordisk (NVO) stake by 16% in Q4 2024, selling an estimated $67.4K and leaving 3,341 shares worth $287K. The position accounts for 0.21% of the portfolio, ranked #79.

Householder Group Estate & Retirement Specialist first reported a position in NVO in Q3 2022 and has held it in 8 quarters since. The position peaked at $567K in Q2 2024. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Householder Group Estate & Retirement Specialist held 3,341 shares of Novo Nordisk worth $287K as of Q4 2024.
  • Householder Group Estate & Retirement Specialist sold 623 Novo Nordisk shares in Q4 2024, an estimated $67.4K.
  • Novo Nordisk made up 0.21% of Householder Group Estate & Retirement Specialist's portfolio in Q4 2024, its #79 holding.
  • Householder Group Estate & Retirement Specialist first reported a position in Novo Nordisk in Q3 2022 and has held it in 8 quarters since.
  • Householder Group Estate & Retirement Specialist's Novo Nordisk position peaked at $567K in Q2 2024.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2024, filed 15 Jan 2025.